MP CARDIOFLOW-B (02160) Income Statement & Earnings

1.280
0.0000.00%

15min DelayMarket Closed Sep 18 09:20 CST

1.63BMarket Cap-11.13P/E (TTM)

MP CARDIOFLOW-B (02160) Income Statement

Cumulative·All

YOY

Hide blank lines

Currency: USD

2025/FY

2025/H1

2024/FY

2024/H1

2023/FY

2023/H1

2022/FY

2022/H1

2021/FY

2021/H1

2020/FY

2019/FY

2018/FY

Total Revenue

+12.28%57.04M

+2.67%229.10M

-84.89%50.81M

+26.47%223.14M

+33.94%336.22M

+41.40%176.44M

+25.00%251.03M

+44.77%124.78M

+93.21%200.81M

--86.19M

+383.37%103.93M

--21.50M

----

Operating Revenue

+12.28%57.04M

+2.67%229.10M

-84.89%50.81M

+26.47%223.14M

+33.94%336.22M

+41.40%176.44M

+25.00%251.03M

+44.77%124.78M

+93.21%200.81M

--86.19M

+383.37%103.93M

--21.50M

----

Cost of Revenue

-28.87%-19.98M

-5.03%-68.18M

+85.41%-15.51M

-8.52%-64.91M

-19.56%-106.28M

-31.94%-59.82M

-8.26%-88.90M

-17.21%-45.34M

-40.23%-82.11M

---38.68M

-285.22%-58.55M

---15.20M

----

Cost of Goods Sold

-28.87%-19.98M

-5.03%-68.18M

+85.41%-15.51M

-8.52%-64.91M

-19.56%-106.28M

-31.94%-59.82M

-8.26%-88.90M

-17.21%-45.34M

-40.23%-82.11M

---38.68M

-285.22%-58.55M

---15.20M

----

Gross Profit

+4.99%37.06M

+1.71%160.92M

-84.65%35.30M

+35.67%158.22M

+41.82%229.93M

+46.80%116.62M

+36.59%162.13M

+67.21%79.44M

+161.57%118.70M

--47.51M

+620.09%45.38M

--6.30M

----

Operating Expense

-4.05%-51.79M

+17.30%-165.04M

+91.43%-49.77M

+22.60%-199.56M

-7.30%-580.75M

-48.50%-257.82M

-93.67%-541.26M

-69.62%-173.62M

-8.26%-279.48M

---102.36M

-81.41%-258.16M

-136.30%-142.31M

---60.22M

Selling Expenses

-13.89%-26.38M

+9.01%-79.31M

+89.61%-23.16M

-0.40%-87.16M

-38.71%-223.01M

-42.20%-86.81M

-38.11%-160.78M

-54.65%-61.05M

-126.68%-116.42M

---39.48M

-96.73%-51.36M

-178.28%-26.11M

---9.38M

Administrative Expenses

-43.03%-11.58M

-22.48%-38.90M

+88.47%-8.10M

-11.36%-31.76M

+2.46%-70.22M

+15.98%-28.52M

-103.63%-71.99M

-144.45%-33.94M

+21.82%-35.35M

---13.88M

-316.66%-45.22M

-78.01%-10.85M

---6.10M

Research and Development Expenses

+32.90%-14.46M

+38.13%-51.41M

+90.92%-21.56M

+24.11%-83.09M

-6.06%-237.34M

-37.54%-109.49M

-48.07%-223.78M

-62.48%-79.61M

-56.06%-151.13M

---49.00M

-0.14%-96.84M

-116.11%-96.70M

---44.75M

Impairment and Provision

----

---49.10M

----

-Impairment of Intangible Assets

----

---49.10M

----

Revaluation Surplus

-79.07%637.00K

+86.89%4.58M

+106.06%3.04M

+107.42%2.45M

-40.94%-50.18M

-3463.81%-33.00M

-252.03%-35.61M

--981.00K

+136.17%23.42M

----

-648.56%-64.74M

---8.65M

----

-Changes in The Fair Value of Other Assets

-79.07%637.00K

+86.89%4.58M

+106.06%3.04M

+107.42%2.45M

-40.94%-50.18M

-3463.81%-33.00M

-252.03%-35.61M

--981.00K

+136.17%23.42M

----

-648.56%-64.74M

---8.65M

----

Special Items of Operating Income

-69.52%1.73M

-38.32%7.93M

-84.74%5.67M

+122.46%12.86M

+1357.49%37.17M

+163.27%5.78M

+65.26%2.55M

-473.01%-9.14M

+103.89%1.54M

--2.45M

-1091.17%-39.72M

+317.40%4.01M

--960.00K

Operating Profit

-47.66%-12.99M

+113.40%3.82M

+97.19%-8.80M

+78.97%-28.48M

+16.71%-313.65M

-31.08%-135.42M

-136.49%-376.58M

-97.17%-103.31M

+36.93%-159.24M

---52.40M

-91.29%-252.50M

-122.73%-132.00M

---59.26M

Financing Cost

-185.05%-1.60M

-55.32%-3.14M

+86.45%-562.00K

+9.33%-2.02M

+23.36%-4.15M

+23.53%-2.23M

+72.81%-5.41M

+82.91%-2.92M

+86.40%-19.90M

---17.06M

-1068.31%-146.31M

-1153.55%-12.52M

---999.00K

Share of Profits of Associates

+16.79%-7.21M

-13.69%-26.79M

+82.57%-8.67M

-0.25%-23.56M

-3.17%-49.72M

-53.35%-23.50M

-1276.07%-48.19M

---15.33M

---3.50M

----

Share of Profit from Joint Venture Company

----

+30.22%-14.74M

-206700.00%-14.48M

-211090.00%-21.12M

+93.75%-7.00K

-101.40%-10.00K

---112.00K

--716.00K

----

Pretax Profit

-177.42%-18.04M

+101.78%960.00K

+98.60%-6.50M

+69.22%-54.06M

-2.72%-463.58M

-44.48%-175.63M

-147.08%-451.30M

-74.74%-121.56M

+54.12%-182.65M

---69.57M

-175.45%-398.09M

-139.82%-144.52M

---60.26M

Special Items of Pretax Income

-67.28%3.77M

--27.07M

+114.17%11.53M

----

---81.33M

----

Tax

+19.82%-789.00K

+14.44%-3.16M

+87.63%-984.00K

+2.20%-3.69M

-156.85%-7.95M

-359.00%-3.77M

-405.06%-3.10M

-64.73%-822.00K

---613.00K

---499.00K

----

Net Profit

-151.49%-18.82M

+96.20%-2.20M

+98.41%-7.49M

+67.81%-57.75M

-3.77%-471.53M

-46.59%-179.40M

-147.95%-454.40M

-74.67%-122.38M

+53.96%-183.26M

---70.07M

-175.45%-398.09M

-139.82%-144.52M

---60.26M

Profit from Continuing Operations

-151.49%-18.82M

+96.20%-2.20M

+98.41%-7.49M

+67.81%-57.75M

-3.77%-471.53M

-46.59%-179.40M

-147.95%-454.40M

-74.67%-122.38M

+53.96%-183.26M

---70.07M

-175.45%-398.09M

-139.82%-144.52M

---60.26M

Minority Interests

+99.07%-5.00K

+97.37%-34.00K

---537.00K

---1.29M

----

Net Income to Parent Company

-170.85%-18.82M

+96.17%-2.16M

+98.53%-6.95M

+68.53%-56.46M

-3.77%-471.53M

-46.59%-179.40M

-147.95%-454.40M

-74.67%-122.38M

+53.96%-183.26M

---70.07M

-175.45%-398.09M

-139.82%-144.52M

---60.26M

Net Income to Common Stockholders

-170.85%-18.82M

+96.17%-2.16M

+98.53%-6.95M

+68.53%-56.46M

-3.77%-471.53M

-46.59%-179.40M

-147.95%-454.40M

-74.67%-122.38M

+53.96%-183.26M

---70.07M

-175.45%-398.09M

-139.82%-144.52M

---60.26M

Basic EPS

-300.00%-0.04

+96.25%-0.00

+95.00%-0.01

+70.00%-0.02

-5.26%-0.20

-60.00%-0.08

-137.50%-0.19

-66.67%-0.05

+65.22%-0.08

---0.03

-187.50%-0.23

-100.00%-0.08

---0.04

Diluted EPS

-300.00%-0.04

+96.25%-0.00

+95.00%-0.01

+70.00%-0.02

-5.26%-0.20

-60.00%-0.08

-137.50%-0.19

-66.67%-0.05

+65.22%-0.08

---0.03

-187.50%-0.23

-100.00%-0.08

---0.04

Deadline

Dec 31, 2025

Jun 30, 2025

Dec 31, 2024

Jun 30, 2024

Dec 31, 2023

Jun 30, 2023

Dec 31, 2022

Jun 30, 2022

Dec 31, 2021

Jun 30, 2021

Dec 31, 2020

Dec 31, 2019

Dec 31, 2018

Accounting Standard

HKAS

Audit Opinions

Unqualified opinion

	2025/FY	2025/H1	2024/FY	2024/H1	2023/FY	2023/H1	2022/FY	2022/H1	2021/FY	2021/H1	2020/FY	2019/FY	2018/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"